Both Sarepta Therapeutics and Citigroup provided market analysis on Sarepta's stock on July 9, 2026.
1 report, 1 independent
Updated Jul 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Both Sarepta Therapeutics and Citigroup provided market analysis on Sarepta's stock on July 9, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sarepta Therapeutics
biopharmaceutical company
Nothing else this week.
-
Citigroup
American investment bank and financial services corporation